Cargando…

MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis

BACKGROUND: Excessive and inappropriate immune responses are the hallmark of several autoimmune disorders, including the inflammatory bowel diseases (IBD): Crohn’s disease (CD) and ulcerative colitis (UC). A complex etiology involving both environmental and genetic factors influences IBD pathogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaefer, Jeremy S, Attumi, Taraq, Opekun, Antone R, Abraham, Bincy, Hou, Jason, Shelby, Harold, Graham, David Y, Streckfus, Charles, Klein, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335694/
https://www.ncbi.nlm.nih.gov/pubmed/25886994
http://dx.doi.org/10.1186/s12865-015-0069-0
_version_ 1782358382539177984
author Schaefer, Jeremy S
Attumi, Taraq
Opekun, Antone R
Abraham, Bincy
Hou, Jason
Shelby, Harold
Graham, David Y
Streckfus, Charles
Klein, John R
author_facet Schaefer, Jeremy S
Attumi, Taraq
Opekun, Antone R
Abraham, Bincy
Hou, Jason
Shelby, Harold
Graham, David Y
Streckfus, Charles
Klein, John R
author_sort Schaefer, Jeremy S
collection PubMed
description BACKGROUND: Excessive and inappropriate immune responses are the hallmark of several autoimmune disorders, including the inflammatory bowel diseases (IBD): Crohn’s disease (CD) and ulcerative colitis (UC). A complex etiology involving both environmental and genetic factors influences IBD pathogenesis. The role of microRNAs (miRNAs), noncoding RNAs involved in regulating numerous biological processes, to IBD pathology, in terms of initiation and progression, remains ill-defined. In the present study, we evaluated the relationship between colon, peripheral blood, and saliva whole miRNome expression in IBD patients and non-inflammatory bowel disease (non-IBD) controls to identify miRNAs that could discriminate CD from UC. Quantitative real-time PCR (qRT-PCR) was used to validate and assess miRNA expression. RESULTS: Microarray analysis demonstrated that upwards of twenty six miRNAs were changed in CD and UC colon biopsies relative to the non-IBD controls. CD was associated with the differential expression of 10 miRNAs while UC was associated with 6 miRNAs in matched colon tissues. CD was associated with altered expression of 6 miRNAs while UC was associated with 9 miRNAs in whole blood. Expression of miR-101 in CD patients and miR-21, miR-31, miR-142-3p, and miR-142-5p in UC patients were altered in saliva. CONCLUSIONS: Our results suggest that there is specific miRNA expression patterns associated with UC versus CD in three separate tissue/body fluids (colon, blood, and saliva). Further, the aberrant miRNA expression profiles indicate that miRNAs may be contributory to IBD pathogenesis, or at least reflect the underlying inflammation. Scrutinizing miRNA expression in saliva and blood samples may be beneficial in monitoring or diagnosing disease in IBD patients. A panel of miRNAs (miR-19a, miR-21, miR-31, miR-101, miR-146a, and miR-375) may be used as markers to identify and discriminate between CD and UC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12865-015-0069-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4335694
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43356942015-02-21 MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis Schaefer, Jeremy S Attumi, Taraq Opekun, Antone R Abraham, Bincy Hou, Jason Shelby, Harold Graham, David Y Streckfus, Charles Klein, John R BMC Immunol Research Article BACKGROUND: Excessive and inappropriate immune responses are the hallmark of several autoimmune disorders, including the inflammatory bowel diseases (IBD): Crohn’s disease (CD) and ulcerative colitis (UC). A complex etiology involving both environmental and genetic factors influences IBD pathogenesis. The role of microRNAs (miRNAs), noncoding RNAs involved in regulating numerous biological processes, to IBD pathology, in terms of initiation and progression, remains ill-defined. In the present study, we evaluated the relationship between colon, peripheral blood, and saliva whole miRNome expression in IBD patients and non-inflammatory bowel disease (non-IBD) controls to identify miRNAs that could discriminate CD from UC. Quantitative real-time PCR (qRT-PCR) was used to validate and assess miRNA expression. RESULTS: Microarray analysis demonstrated that upwards of twenty six miRNAs were changed in CD and UC colon biopsies relative to the non-IBD controls. CD was associated with the differential expression of 10 miRNAs while UC was associated with 6 miRNAs in matched colon tissues. CD was associated with altered expression of 6 miRNAs while UC was associated with 9 miRNAs in whole blood. Expression of miR-101 in CD patients and miR-21, miR-31, miR-142-3p, and miR-142-5p in UC patients were altered in saliva. CONCLUSIONS: Our results suggest that there is specific miRNA expression patterns associated with UC versus CD in three separate tissue/body fluids (colon, blood, and saliva). Further, the aberrant miRNA expression profiles indicate that miRNAs may be contributory to IBD pathogenesis, or at least reflect the underlying inflammation. Scrutinizing miRNA expression in saliva and blood samples may be beneficial in monitoring or diagnosing disease in IBD patients. A panel of miRNAs (miR-19a, miR-21, miR-31, miR-101, miR-146a, and miR-375) may be used as markers to identify and discriminate between CD and UC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12865-015-0069-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-10 /pmc/articles/PMC4335694/ /pubmed/25886994 http://dx.doi.org/10.1186/s12865-015-0069-0 Text en © Schaefer et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schaefer, Jeremy S
Attumi, Taraq
Opekun, Antone R
Abraham, Bincy
Hou, Jason
Shelby, Harold
Graham, David Y
Streckfus, Charles
Klein, John R
MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
title MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
title_full MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
title_fullStr MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
title_full_unstemmed MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
title_short MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
title_sort microrna signatures differentiate crohn’s disease from ulcerative colitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335694/
https://www.ncbi.nlm.nih.gov/pubmed/25886994
http://dx.doi.org/10.1186/s12865-015-0069-0
work_keys_str_mv AT schaeferjeremys micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT attumitaraq micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT opekunantoner micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT abrahambincy micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT houjason micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT shelbyharold micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT grahamdavidy micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT streckfuscharles micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis
AT kleinjohnr micrornasignaturesdifferentiatecrohnsdiseasefromulcerativecolitis